Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.301
+0.001 (0.40%)
At close: Mar 9, 2026, 4:00 PM EDT
0.293
-0.008 (-2.52%)
After-hours: Mar 9, 2026, 5:21 PM EDT
Cue Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 27 | 69 | 119 | 123 | 359 | 379 | |
| Market Cap Growth | -68.36% | -42.03% | -2.89% | -65.85% | -5.17% | 3.77% | |
| Enterprise Value | 13 | 46 | 81 | 83 | 295 | 295 | |
| Last Close Price | 0.30 | 1.09 | 2.64 | 2.85 | 11.31 | 12.51 | |
| PS Ratio | 3.85 | 7.44 | 21.70 | 98.53 | 24.04 | 120.08 | |
| PB Ratio | 1.76 | 3.95 | 3.21 | 1.87 | 5.49 | 4.80 | |
| P/TBV Ratio | 2.07 | 3.95 | 3.21 | 1.87 | 5.49 | 4.80 | |
| EV/Sales Ratio | 1.85 | 4.97 | 14.72 | 66.75 | 19.76 | 93.58 | |
| Debt / Equity Ratio | 0.47 | 0.51 | 0.40 | 0.29 | 0.15 | 0.09 | |
| Net Debt / Equity Ratio | -1.07 | -0.83 | -0.92 | -0.87 | -0.83 | -0.98 | |
| Net Debt / EBITDA Ratio | 0.38 | 0.35 | 0.66 | 1.08 | 1.28 | 1.77 | |
| Net Debt / FCF Ratio | 0.48 | 0.40 | 0.85 | 1.36 | 1.37 | 2.35 | |
| Asset Turnover | 0.19 | 0.20 | 0.07 | 0.01 | 0.16 | 0.04 | |
| Quick Ratio | 1.46 | 1.78 | 2.96 | 6.61 | 5.28 | 5.29 | |
| Current Ratio | 1.66 | 1.84 | 3.01 | 6.68 | 5.35 | 5.37 | |
| Return on Equity (ROE) | -195.19% | -149.03% | -98.73% | -80.82% | -61.16% | -67.10% | |
| Return on Assets (ROA) | -62.30% | -55.47% | -42.53% | -38.29% | -29.87% | -32.90% | |
| Return on Capital Employed (ROCE) | -236.40% | -224.80% | -117.00% | -67.10% | -61.90% | -54.10% | |
| Earnings Yield | -137.77% | -58.90% | -42.59% | -43.21% | -12.29% | -11.82% | |
| FCF Yield | -109.01% | -52.71% | -33.55% | -34.22% | -11.07% | -8.74% | |
| Buyback Yield / Dilution | -74.30% | -23.11% | -28.35% | -13.95% | -9.05% | -30.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.